In recent years, in vitro diagnosis (IVD) has been developing rapidly in China, with a domestic market capacity of 70 billion yuan and an average annual growth rate of nearly 20% in five years. IVD has become the largest and fastest growing segment of the whole medical device market. Since its establishment in 2005, desheng technology has only used vasculture-related reagents. Later, it has gradually developed in vitro diagnostic materials such as chromogenic substrate, biological buffer and chemical luminescence agent.
With the rise of domestic in vitro diagnosis manufacturers, raw material companies in recent years showed a rapid development trend. There were only 23 raw material companies founded before 2010, and as many as 44 in 2010 and beyond. In the three years from 2016 to 2018, more than 17 new raw material companies were established, an average of 6 a year. Domestic IVD raw material competition is intense.
By city, Beijing leads the pack, accounting for more than a quarter of the total. Hangzhou, shenzhen and wuhan are in the second tier. The other 34 are widely distributed across the country. Similar to the distribution of chemiluminescence manufacturers, the raw material manufacturers are also distributed in the southeast region centered in Beijing, Shanghai, guangzhou-shenzhen, while only chongqing and chengdu are slightly distributed in the central and western regions.
However, at the same time, with the gradually intensified competition in the IVD terminal market, the war of IVD has also been led to the upstream raw material field. China's IVD raw material industry is also facing an embarrassing position similar to the chip in IT. Many IVD manufacturers have the experience of ordering imported raw materials from unconventional channels (Europe, America or Japan). The reason is that the core raw materials are monopolized by these import manufacturers. IVD manufacturers in China are in a very weak position in the price negotiation, and the phenomenon of being controlled by others is very obvious. Of course, domestic reagent also presents the trend of gradually replacing imported reagent. More and more enterprises begin to use domestic reagent raw materials.
DE sheng technology since the 05 years began to research and development production of separation, heparin, EDTA potash mining vessel additives, and in vitro diagnostic reagent, the color of the original substrate TOOS, MAOS new Trinder 's reagent, Bicine and Tris biological buffer and luminol, acridine esters such as chemiluminescence reagent has a deep research, in the independent research and development and synthesis of professional advantage.
Contact Person: Miss. Ankiwang